Is Positron Emission Tomography Reliable to PredictPost-Chemotherapy Retroperitoneal Lymph NodeInvolvement in Advanced Germ Cell Tumors of theTestis?

PURPOSE: To evaluate if 18 fluorodeoxyglucose positron emission tomography(18FDG-PET) scan could identify post-chemotherapy retroperitoneal lymphnode (RPLN) involvement in advanced germ cell tumors of the testis.MATERIALS AND METHODS: Between January 2005 and January 2009, 16patients with advanced g...

Full description

Bibliographic Details
Main Authors: Ziya Akbulut, Abdullah Erdem Canda, Ali Fuat Atmaca, Alper Caglayan, Erem Asil, Mevlana Derya Balbay
Format: Article
Language:English
Published: Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences 2011-06-01
Series:Urology Journal
Subjects:
Online Access:http://www.urologyjournal.org/index.php/uj/article/view/1022/548
_version_ 1818477160025817088
author Ziya Akbulut
Abdullah Erdem Canda
Ali Fuat Atmaca
Alper Caglayan
Erem Asil
Mevlana Derya Balbay
author_facet Ziya Akbulut
Abdullah Erdem Canda
Ali Fuat Atmaca
Alper Caglayan
Erem Asil
Mevlana Derya Balbay
author_sort Ziya Akbulut
collection DOAJ
description PURPOSE: To evaluate if 18 fluorodeoxyglucose positron emission tomography(18FDG-PET) scan could identify post-chemotherapy retroperitoneal lymphnode (RPLN) involvement in advanced germ cell tumors of the testis.MATERIALS AND METHODS: Between January 2005 and January 2009, 16patients with advanced germ cell tumors of the testis underwent RPLNdissection (RPLND) following chemotherapy. Before RPLND, abdominalcomputed tomography (CT), magnetic resonance imaging (MRI), and18FDG-PET were performed in all the patients. Findings on 18FDG-PETwere compared with pathological evaluation of the removed lymphatic tissue.RESULTS: Both abdominal CT and MRI demonstrated retroperitonealmasses in all the patients following chemotherapy. Although PET did not demonstrate any activity in 8 patients, tumor was detected histopathologically.In 1 patient, 18FDG-PET demonstrated activity; however, no tumor wasdetected on pathology. Of the remaining 7 patients, 18FDG-PET findingswere concordant with the histopathological findings. No activity wasdetected in 2 patients with no tumors whereas all 5 patients harboring viabletumor cells showed positive 18FDG-PET activity. In our study, sensitivityand specificity of 18FDG-PET in detecting RPLN involvement were detectedto be 39% and 67%, respectively.CONCLUSION: 18FDG-PET imaging does not seem to be a reliable methodin detecting RPLN involvement in advanced germ cell tumors of the testisfollowing chemotherapy. Therefore, we neither recommend routine use of18FDG-PET scanning nor decide the treatment work-up by solely relying onthe 18FDG-PET findings in this patient group.
first_indexed 2024-12-10T09:34:35Z
format Article
id doaj.art-2de09ff3d4e4400093aa0cc42b66352f
institution Directory Open Access Journal
issn 1735-1308
1735-546X
language English
last_indexed 2024-12-10T09:34:35Z
publishDate 2011-06-01
publisher Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences
record_format Article
series Urology Journal
spelling doaj.art-2de09ff3d4e4400093aa0cc42b66352f2022-12-22T01:54:14ZengUrology and Nephrology Research Center, Shahid Beheshti University of Medical SciencesUrology Journal1735-13081735-546X2011-06-0182120126Is Positron Emission Tomography Reliable to PredictPost-Chemotherapy Retroperitoneal Lymph NodeInvolvement in Advanced Germ Cell Tumors of theTestis?Ziya AkbulutAbdullah Erdem CandaAli Fuat AtmacaAlper CaglayanErem AsilMevlana Derya BalbayPURPOSE: To evaluate if 18 fluorodeoxyglucose positron emission tomography(18FDG-PET) scan could identify post-chemotherapy retroperitoneal lymphnode (RPLN) involvement in advanced germ cell tumors of the testis.MATERIALS AND METHODS: Between January 2005 and January 2009, 16patients with advanced germ cell tumors of the testis underwent RPLNdissection (RPLND) following chemotherapy. Before RPLND, abdominalcomputed tomography (CT), magnetic resonance imaging (MRI), and18FDG-PET were performed in all the patients. Findings on 18FDG-PETwere compared with pathological evaluation of the removed lymphatic tissue.RESULTS: Both abdominal CT and MRI demonstrated retroperitonealmasses in all the patients following chemotherapy. Although PET did not demonstrate any activity in 8 patients, tumor was detected histopathologically.In 1 patient, 18FDG-PET demonstrated activity; however, no tumor wasdetected on pathology. Of the remaining 7 patients, 18FDG-PET findingswere concordant with the histopathological findings. No activity wasdetected in 2 patients with no tumors whereas all 5 patients harboring viabletumor cells showed positive 18FDG-PET activity. In our study, sensitivityand specificity of 18FDG-PET in detecting RPLN involvement were detectedto be 39% and 67%, respectively.CONCLUSION: 18FDG-PET imaging does not seem to be a reliable methodin detecting RPLN involvement in advanced germ cell tumors of the testisfollowing chemotherapy. Therefore, we neither recommend routine use of18FDG-PET scanning nor decide the treatment work-up by solely relying onthe 18FDG-PET findings in this patient group.http://www.urologyjournal.org/index.php/uj/article/view/1022/548testicular neoplasmslymph nodespositron-emission tomographysensitivity and specificity
spellingShingle Ziya Akbulut
Abdullah Erdem Canda
Ali Fuat Atmaca
Alper Caglayan
Erem Asil
Mevlana Derya Balbay
Is Positron Emission Tomography Reliable to PredictPost-Chemotherapy Retroperitoneal Lymph NodeInvolvement in Advanced Germ Cell Tumors of theTestis?
Urology Journal
testicular neoplasms
lymph nodes
positron-emission tomography
sensitivity and specificity
title Is Positron Emission Tomography Reliable to PredictPost-Chemotherapy Retroperitoneal Lymph NodeInvolvement in Advanced Germ Cell Tumors of theTestis?
title_full Is Positron Emission Tomography Reliable to PredictPost-Chemotherapy Retroperitoneal Lymph NodeInvolvement in Advanced Germ Cell Tumors of theTestis?
title_fullStr Is Positron Emission Tomography Reliable to PredictPost-Chemotherapy Retroperitoneal Lymph NodeInvolvement in Advanced Germ Cell Tumors of theTestis?
title_full_unstemmed Is Positron Emission Tomography Reliable to PredictPost-Chemotherapy Retroperitoneal Lymph NodeInvolvement in Advanced Germ Cell Tumors of theTestis?
title_short Is Positron Emission Tomography Reliable to PredictPost-Chemotherapy Retroperitoneal Lymph NodeInvolvement in Advanced Germ Cell Tumors of theTestis?
title_sort is positron emission tomography reliable to predictpost chemotherapy retroperitoneal lymph nodeinvolvement in advanced germ cell tumors of thetestis
topic testicular neoplasms
lymph nodes
positron-emission tomography
sensitivity and specificity
url http://www.urologyjournal.org/index.php/uj/article/view/1022/548
work_keys_str_mv AT ziyaakbulut ispositronemissiontomographyreliabletopredictpostchemotherapyretroperitoneallymphnodeinvolvementinadvancedgermcelltumorsofthetestis
AT abdullaherdemcanda ispositronemissiontomographyreliabletopredictpostchemotherapyretroperitoneallymphnodeinvolvementinadvancedgermcelltumorsofthetestis
AT alifuatatmaca ispositronemissiontomographyreliabletopredictpostchemotherapyretroperitoneallymphnodeinvolvementinadvancedgermcelltumorsofthetestis
AT alpercaglayan ispositronemissiontomographyreliabletopredictpostchemotherapyretroperitoneallymphnodeinvolvementinadvancedgermcelltumorsofthetestis
AT eremasil ispositronemissiontomographyreliabletopredictpostchemotherapyretroperitoneallymphnodeinvolvementinadvancedgermcelltumorsofthetestis
AT mevlanaderyabalbay ispositronemissiontomographyreliabletopredictpostchemotherapyretroperitoneallymphnodeinvolvementinadvancedgermcelltumorsofthetestis